Accuracy of whole genome sequencing to determine recent tuberculosis transmission: an 11-year population-based study in Hamburg, Germany
- Roland Diel1,2,&⇑,
- Thomas A. Kohl3,4,&,
- Florian Mauer4,
- Matthias Merker3,4,
- Karen Meywald Walter5,
- Jörg Hannemann5,
- Albert Nienhaus2,6,
- Philip Supply7,8,9,10 and
- Stefan Niemann3,4
- 1Institute for Epidemiology, Schleswig-Holstein University Hospital, Kiel, Germany
- 2Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services (BGW), Hamburg, Germany
- 3Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany
- 4German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany
- 5Public Health Department Hamburg-Central, Hamburg, Germany
- 6Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Germany
- 7Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- 8Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8204, Center for Infection and Immunity of Lille, Lille, France
- 9Université Lille Nord de France, Center for Infection and Immunity of Lille, Lille, France
- 10Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France
- Prof. Roland Diel. E-mail: roland.diel{at}epi.uni-kiel.de
& equal contribution
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Diel has nothing to disclose.
Conflict of interest: Dr. Kohl has nothing to disclose.
Conflict of interest: Dr. Maurer has nothing to disclose.
Conflict of interest: Dr. Merker has nothing to disclose.
Conflict of interest: Dr. Meywald-Walter has nothing to disclose.
Conflict of interest: Dr. Hannemann has nothing to disclose.
Conflict of interest: Dr. Nienhaus has nothing to disclose.
Conflict of interest: Dr. Supply reports other from Genoscreen, during the conduct of the study.
Conflict of interest: Dr. Niemann reports grants from German Center for Infection Research, grants from Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy – EXC 22167-390884018“, grants from Leibniz Science Campus EvoLUNG, during the conduct of the study.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2019